LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Nasdaq Composite gaining around 150 points on Wednesday. Shares of LuxExperience BV-ADR (NYSE: LUXE ) rose sharply after the company reported fourth-quarter results. LuxExperience reported quarterly losses of 21 cents per share which missed the analyst consensus estimate of losses of 14 cents per share. The company reported quarterly sales of $771.703 million which beat the analyst consensus estimate of $727.390 million. LuxExperience shares jumped 13.5% to $8.10 on Wednesday. Here are some other big stocks recording gains in today’s session. Einride AB (NASDAQ: ENRD ) gained 10.5% to $4.14.. Canaccord Genuity analyst George Gianarikas, on Tuesday, initiated coverage on Einride with a Buy rating and announced a price target of $8. Forgent Power Solutions, Inc (NYSE: FPS ) gained 9.7% to $34.40. Forgent Power Solutions, on Tuesday, reported strong fourth-quarter results and issued fiscal 2027 guidance above estimates. Cipher Digital In c (NASDAQ: CIFR ) gained 9.7% to $16.56. Beta Bionics In c (NASDAQ: BBNX ) gained 8.6% to $20.90 after the company reported the pricing of public offering of common stock and pre-funded warrants. New Found Gold Corp (N
S. stocks were mixed, with the Nasdaq Composite gaining around 150 points on Wednesday. Shares of LuxExperience BV-ADR (NYSE: LUXE ) rose sharply after the company reported fourth-quarter results. LuxExperience reported quarterly losses of 21 cents per share which missed the analyst consensus estimate of losses of 14 cents per share.
390 million. 10 on Wednesday. Here are some other big stocks recording gains in today’s session. 14..
Canaccord Genuity analyst George Gianarikas, on Tuesday, initiated coverage on Einride with a Buy rating and announced a price target of $8. 40. Forgent Power Solutions, on Tuesday, reported strong fourth-quarter results and issued fiscal 2027 guidance above estimates. 56.
90 after the company reported the pricing of public offering of common stock and pre-funded warrants. 76. 41. Barclays analyst Glen Santangelo upgraded the stock from Underweight to Overweight and raised the price target from $4 to $8.
58. 04. 26. Worthington Enterprises will hold its quarterly earnings conference call on Wednesday, Sept.
23. 37. 42. Twist Bioscience announced an agreement with Lilly TuneLab to advance antibody drug discovery.
08. 00. 64. S.
for the first time. Photo via Shutterstock